Study summary

The objective of this study is to confirm efficacy of ASP1941 based on the changes in HbA1c and to assess its safety in subjects with type 1 diabetes mellitus receiving ASP1941 once daily in combination with insulin for 24 weeks. This study will also assess the safety/efficacy of long-term treatment (52 weeks).

Additional Study Details

Phase
3
Product
N/A
Product
ipragliflozin
Placebo
Type
Interventional
Masking
Double (Participant, Investigator)
Enrollment number
175
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): Japanese

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Study of ASP1941 in Combination with Insulin in Patients with Type 1 Diabetes Mellitus? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Site JP00024
    Nagasaki, Nagasaki, Japan
    Completed
    Site JP00016
    Kanagawa, Kanagawa, Japan
    Completed
    Site JP00034
    Hokkaido, Hokkaido, Japan
    Completed
    Site JP00023
    Fukuoka, Fukuoka, Japan
    Completed
    Site JP00019
    Mie, Mie, Japan
    Completed
    Site JP00001
    Tochigi, Tochigi, Japan
    Completed
    Site JP00015
    Kanagawa, Kanagawa, Japan
    Completed
    Site JP00030
    Tokushima, Tokushima, Japan
    Completed
    Site JP00026
    Niigata, Niigata, Japan
    Completed
    Site JP00011
    Gunma, Gunma, Japan
    Completed
    Site JP00031
    Fukuoka, Fukuoka, Japan
    Completed
    Site JP00010
    Ibaraki, Ibaraki, Japan
    Completed
    Site JP00003
    Chiba, Chiba, Japan
    Completed
    Site JP00014
    Tokyo, Tokyo, Japan
    Completed
    Site JP00008
    Nagasaki, Nagasaki, Japan
    Completed
    Site JP00029
    Osaka, Osaka, Japan
    Completed
    Site JP00017
    Shizuoka, Shizuoka, Japan
    Completed
    Site JP00035
    Chiba, Chiba, Japan
    Completed
    Site JP00007
    Yamaguchi, Yamaguchi, Japan
    Completed
    Site JP00018
    Shizuoka, Shizuoka, Japan
    Completed
    Site JP00032
    Nagasaki, Nagasaki, Japan
    Completed
    Site JP00006
    Hiroshima, Hiroshima, Japan
    Completed
    Site JP00022
    Fukuoka, Fukuoka, Japan
    Completed
    Site JP00033
    Hokkaido, Hokkaido, Japan
    Completed
    Site JP00027
    Toyama, Toyama, Japan
    Completed
    Site JP00009
    Ibaraki, Ibaraki, Japan
    Completed
    Site JP00021
    Hyogo, Hyogo, Japan
    Completed
    Site JP00028
    Aichi, Aichi, Japan
    Completed
    Site JP00020
    Osaka, Osaka, Japan
    Completed
    Site JP00036
    Osaka, Osaka, Japan
    Completed
    Site JP00025
    Nagasaki, Nagasaki, Japan
    Completed
    Site JP00012
    Saitama, Saitama, Japan
    Completed
    Site JP00004
    Kanagawa, Kanagawa, Japan
    Completed
    Site JP00005
    Aichi, Aichi, Japan
    Completed
    Site JP00013
    Chiba, Chiba, Japan
    Completed
    Site JP00002
    Gunma, Gunma, Japan

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?